Skip to main content
Recall Canary
Physio-Control Infant/Child Defibrillator Electrodes
← Back to all recalls
MEDICAL DEVICE RECALLMODERATE

Physio-Control Infant/Child Defibrillator Electrodes

Physio-Control is recalling infant/child defibrillator electrodes due to a risk of delamination that could impact therapy delivery.

What to do

Immediately stop using the affected electrodes and contact Physio-Control or your authorized distributor for replacement instructions.

Recalled
Listed
Updated
Recall No.
Z-1544-2026
Agency
FDA
Firm
Physio-Control, Inc.
Recall ID
98257
Status
ONGOING

Recall at a glance

Quantity recalled
16,499 electrodes (US/OUS: 8327/8172)

Why it was recalled

Physio-Control is recalling specific infant and child reduced energy defibrillator electrodes due to potential delamination of the electrode, which may prevent effective therapy delivery. The affected products were distributed nationwide.

Is mine affected?

Check the model, lot, or serial number on the device or its packaging. Yours is affected if it matches one below.

ProductUDI-DI
PHYSIO CONTROL INFANT/CHILD Reduced Energy Defibrillator Electrodes Catalog Numbers: 11101-000016 UDI-DI code: 00721902629013 Catalog Number: 11101-000017 UDI-DI code: 00721902682483 Infant/Child Reduced Energy Defibrillation Electrodes are pre gelled, self-adhesive, therapy electrodes that allow hands free defibrillation. These electrodes reduce the energy delivered to the patient by a factor of 4:1. The Infant/child reduced energy defibrillation electrodes are therapy electrodes desig00721902629013, 00721902682483
Catalog Numbers: 11101-00001600721902629013
Catalog Number: 11101-00001700721902682483

Where it was sold

Distributed nationwide.

Timeline

  1. Firm initiated recall
  2. Publicly announced
  3. Listed on Recall Canary
  4. Summary updated

Other recent recalls from Physio-Control, Inc.

All recalls from Physio-Control, Inc.

← Back to all recalls

Editorial summary by Recall Canary · summary updated 2026-06-11 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification